Invesco LLC Buys 2,460 Shares of Agilent Technologies, Inc. (NYSE:A)

Invesco LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 11.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,062 shares of the medical research company's stock after buying an additional 2,460 shares during the period. Agilent Technologies comprises about 1.2% of Invesco LLC's investment portfolio, making the stock its 24th biggest holding. Invesco LLC's holdings in Agilent Technologies were worth $2,815,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Flynn Zito Capital Management LLC boosted its position in Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock valued at $251,000 after buying an additional 69 shares during the period. IFP Advisors Inc boosted its position in Agilent Technologies by 17.7% during the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock valued at $62,000 after buying an additional 69 shares during the period. Tiemann Investment Advisors LLC lifted its position in shares of Agilent Technologies by 5.6% in the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company's stock worth $191,000 after purchasing an additional 75 shares during the period. Rothschild Investment LLC lifted its position in shares of Agilent Technologies by 19.2% in the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock worth $66,000 after purchasing an additional 79 shares during the period. Finally, CIBC Private Wealth Group LLC lifted its position in shares of Agilent Technologies by 1.2% in the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock worth $1,025,000 after purchasing an additional 87 shares during the period.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on A. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Wall Street Zen cut shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, June 14th. Barclays raised their target price on shares of Agilent Technologies from $115.00 to $125.00 and gave the stock an "equal weight" rating in a research report on Tuesday. Robert W. Baird dropped their target price on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Finally, Jefferies Financial Group dropped their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Eight research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of "Hold" and a consensus target price of $140.92.

Agilent Technologies Stock Down 0.2%

NYSE A traded down $0.22 during trading hours on Friday, reaching $119.20. 1,734,703 shares of the company's stock traded hands, compared to its average volume of 1,882,503. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The firm has a market cap of $33.86 billion, a PE ratio of 29.43, a PEG ratio of 3.62 and a beta of 1.23. The firm has a 50-day simple moving average of $112.19 and a 200 day simple moving average of $123.92. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. During the same period last year, the company posted $1.22 EPS. Agilent Technologies's revenue was up 6.0% on a year-over-year basis. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.83%. Agilent Technologies's dividend payout ratio is currently 24.44%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at approximately $4,161,931.02. This trade represents a 4.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.